Persistence of occult metastatic cells in bone marrow after adjuvant systemic therapy predicts relapse in localized breast cancer.

被引：0
|
作者：
Bermejo, B
Lluch, A
Benet, I
Sastre, JM
Ferrer, JV
Garcia, T
Chumbes, L
Martinez, P
Garcia-Conde, J
机构：
[1] Hosp Clin, Dept Hematol & Oncol, Valencia, Spain
[2] Univ Valencia, Dept Stat, E-46003 Valencia, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
657
引用
收藏
页码：41S / 41S
页数：1
相关论文
共 50 条
  • [21] Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer:: Results at 4 years
    Slade, MJ
    Singh, A
    Smith, BM
    Tripuraneni, G
    Hall, E
    Peckitt, C
    Fox, S
    Graham, H
    Lüchtenborg, M
    Sinnett, HD
    Cross, NCP
    Coombes, RC
    INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (01) : 94 - 100
  • [22] Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse
    Braun, S
    Schindlbeck, C
    Hepp, F
    Janni, W
    Kentenich, C
    Reithmüller, G
    Pantel, K
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 368 - 375
  • [23] Trastuzumab use at relapse after adjuvant trastuzumab therapy in HER2-positive breast cancer.
    Lang, I.
    Bell, R.
    Feng, F.
    Lopez, R. I.
    Jassem, J.
    Semiglazov, V.
    Al-Sakaff, N.
    Carreras, E.
    Chang, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [24] Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse
    Chidananda M. Siddappa
    Sreeraj G. Pillai
    Jackie Snider
    Patsy Alldredge
    Kathyrn Trinkaus
    Mark A. Watson
    Rebecca Aft
    Breast Cancer Research and Treatment, 2019, 178 : 317 - 325
  • [25] Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse
    Siddappa, Chidananda M.
    Pillai, Sreeraj G.
    Snider, Jackie
    Alldredge, Patsy
    Trinkaus, Kathyrn
    Watson, Mark A.
    Aft, Rebecca
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (02) : 317 - 325
  • [26] Association of persistence of isolated tumor cells (ITC) in bone marrow (BM) of breast cancer patients with risk for relapse
    Janni, W
    Rack, B
    Schindlbeck, C
    Strobl, B
    Rjosk, D
    Braun, S
    Sommer, H
    Pantel, K
    Gerber, B
    Friese, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 22S - 22S
  • [27] Implications of occult metastatic cells for systemic cancer treatment in patients with breast or gastrointestinal cancer
    Braun, S
    Rosenberg, R
    Thorban, S
    Harbeck, N
    SEMINARS IN SURGICAL ONCOLOGY, 2001, 20 (04): : 334 - 346
  • [28] Mapping spatial cellular dynamics of bone marrow niches in metastatic breast cancer.
    He, Tiancheng
    Zhang, Weijie
    Li, Jiasong
    Sheng, Jianting
    Zhang, Xiang
    Wong, Stephen T.
    CANCER RESEARCH, 2021, 81 (13)
  • [29] ADJUVANT SYSTEMIC THERAPY AND SURVIVAL AFTER BREAST-CANCER
    OLIVOTTO, IA
    BAJDIK, CD
    PLENDERLEITH, IH
    COPPIN, CM
    GELMON, KA
    JACKSON, SM
    RAGAZ, J
    WILSON, KS
    WORTH, A
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (12): : 805 - 810
  • [30] Persistence of disseminated tumor cells (DTC) in bone marrow (BM) of breast cancer patients predicts increased risk for relapse - Results of pooled European data.
    Janni, W. J.
    Wiedswang, G.
    Fehm, T.
    Jueckstock, J.
    Borgen, E.
    Rack, B.
    Braun, S.
    Sommer, H.
    Pantel, K.
    Naume, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 561S - 561S
12345